Events
ASRS 2026: industry highlights and product innovations
Annual retina specialists meeting kicks off in Montreal with immersive, interactive experiences and technology showcases.
Events
ASRS 2026: your retina research rundown
Annual meeting of retina specialists kicks off in Montreal with updates on the latest clinical findings shaping the future of retina research.
Business
ASRS names new 2024-2025 president
Retinal specialist and vitreoretinal surgeon Reginald J. Sanders, MD, FASRS, has taken over leadership.
Products
ASRS reports safety concerns over Apellis' Syfovre
A reported six cases of retinal vasculitis have occurred in patients following the first intravitreal injection, the organization says.
Pipeline
4DMT reports new phase 2b gene therapy data for wet AMD
New 2-year data demonstrates an overall 78% treatment reduction in patients treated with 4D-150 compared to bimonthly 2 mg aflibercept.
Pipeline
Belite Bio presents updated phase 3 data on oral tinlarebant for Stargardt
Findings released at ASRS highlight an 80% reduction in key protein implicated in Stargardt disease after 2 years.
Research
Adverum reports 5-year extension data on wet AMD gene therapy
At ASRS 2026, the OPTIC extension finds a single Ixo-vec injection led to a 87% cumulative reduction in annualized anti-VEGF injections.
Research
Real-world pegcetacoplan data shows VA benefits through 18 months
EHR and AI-based imaging analysis presented at ASRS demonstrates SYFOVRE advantages extending to GA patients with concomitant wet AMD.Research
New SYFOVRE data extend GA benefit to patients with concurrent wet AMD
SYFOVRE demonstrates reduced photoreceptor and RPE loss in GA patients and those with concomitant nAMD.
Research
Real-world data finds anti-VEGF use may not disrupt IZERVAY dosing patterns
IRIS Registry study demonstrates similarities in safety and dosing intervals among patients undergoing concomitant anti-VEGF and IZERVAY therapy.
Products
Eyes On Eyecare launches retina research-based app
Cited for Retina offers a “PubMed meets Instagram Stories” way for retina specialists to discover, digest, and react to new research shaping their practice.
Pipeline
4DMT releases 60-week phase 2 analysis on DME gene therapy
Reported at ASRS, data supports sustained vision gains and a 78% reduction in supplemental injections for 4D-150’s highest dose as company preps for phase 3 trial.
Pipeline
RegenxBio doses first patient in phase 2b/3 trial for DR
One-time gene therapy continues to move down the pipeline, with presentations on efficacy and safety data expected at ASRS.
Research
Genentech reports 5-year results on SUSVIMO for wet AMD
Presented at ASRS, new data reinforce the ranibizumab injection’s ability to provide an immediate and predictable durability as an alternative to regular eye injections.
Business
Apellis names retinal specialist as chief medical retina advisor
Former ASRS President Philip Ferrone, MD, will assume the role on March 18.
Products
Eyedaptic launches AI visual assistant for smart glasses
Eva integrates with the E7 as a new category of intuitive and responsive assistive tech offering the ability to infer, reason, and take action in real time.
Pipeline
Nacuity doses first patient in phase 3 trial on oral therapy for RP associated with Usher syndrome
Sites in the U.S. and Australia are actively enrolling patients for the SLO-RP Preserve trial.
Products
EyeDock debuts AI clinical assistant for ECPs
Online clinical reference and toolkit now comes with a virtual assistant for answering questions from a curated database of contact lenses, medications, conditions, and codes.
Research
New research confirms association of OSA with glaucoma
Real-world cohort study indicates patients with obstructive sleep apnea may have a higher long-term risk of developing glaucoma.
Research